(HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Multiple Sclerosis
This study will evaluate an investigational drug for relapsing remitting multiple sclerosis. You may qualify if you are 18 to 55 and have had a relapse within the last year.
The research site is in Sarasota, Fla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/multiple_sclerosis.aspx.
—–
Migraines
This study, for people 18 or older, will evaluate the safety and effectiveness of two FDA approved medications to treat migraines.
The research site is in Raleigh, N.C.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/migraine.aspx.
—–
Diabetic Peripheral Neuropathy (DPN)
Participants in this study of diabetes pain may receive study-related medical evaluations and medication at no cost, and compensation for time and travel.
The research site is in Alexandria, Va.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/peripheral_neuropathy.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.